Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Presbia stock

LENSF
IE00BJ0X7W22

Price

0.02
Today +/-
+0
Today %
+0 %

Presbia stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Presbia stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Presbia stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Presbia stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Presbia's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Presbia Stock Price History

DatePresbia Price
9/26/20210.02 undefined
9/14/20210.02 undefined

Presbia Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Presbia, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Presbia from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Presbia’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Presbia. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Presbia’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Presbia’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Presbia’s growth potential.

Presbia Revenue, EBIT and net profit per share

DatePresbia RevenuePresbia EBITPresbia Net Income
201821,000 undefined-8.55 M undefined-8.46 M undefined
201714,000 undefined-16.72 M undefined-17 M undefined
201614,000 undefined-15.66 M undefined-15.76 M undefined
2015153,000 undefined-18.13 M undefined-18.16 M undefined
2014161,000 undefined-13.35 M undefined-15.66 M undefined
201398,000 undefined-7.28 M undefined-9.46 M undefined
2012100,000 undefined-3.59 M undefined-5.05 M undefined
2011210,000 undefined-2.02 M undefined-2.89 M undefined

Presbia Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018
00000000
--------
--------
00000000
-2-5-9-15-18-15-16-8
-150.0080.0066.6720.00-16.676.67-50.00
13.3313.3313.339.1712.9513.3416.317.08
--------
Details

Keystats

ⓘ

Revenue and Growth

The Presbia Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Presbia is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20112012201320142015201620172018
               
0.150.180.580.1421.757.333.242.53
501020251163820
00000000
14020019937843030212759
40180146122242392108175
0.380.570.950.6622.548.033.482.78
30720820747775727477367
00000000
00000000
0.010.0100.050.031.491.481.34
00000000
00.081.990.890.060.130.130.04
0.040.812.821.680.872.352.081.75
0.421.383.762.3423.4110.385.564.53
               
0005467677171
0.090.1412.8436.6377.5179.6891.3698.24
-7.21-12.26-21.72-37.39-55.55-71.3-88.3-96.76
00000000
00000000
-7.12-12.12-8.88-0.7122.028.443.131.54
0.060.242.651.880.740.40.630.61
130100191364340000
0.020.080.350.350.280.651.170.34
000004904800
000000020
0.210.423.192.591.361.542.280.97
6.0110.277.180.4200.3701.92
00000000
1.322.812.280.040.020.030.150.11
7.3313.089.460.450.020.40.152.02
7.5413.512.653.051.381.942.432.99
0.421.383.762.3423.4110.385.564.53
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Presbia provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Presbia's financial health and stability.

Assets

Presbia's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Presbia must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Presbia after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Presbia's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20112012201320142015201620172018
-2-5-9-15-18-15-16-8
00000000
00000000
0000001,0000
12362210
00000000
00000000
-1-3-4-9-15-13-13-8
00000000
00000000
00000000
00000000
00000002
0000380104
1359370107
1359-1000
00000000
000021-14-40
-1.79-3.73-4.97-9.69-15.85-13.55-14.04-8.36
00000000

Presbia stock margins

The Presbia margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Presbia. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Presbia.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Presbia's sales revenue. A higher gross margin percentage indicates that the Presbia retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Presbia's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Presbia's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Presbia's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Presbia. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Presbia's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Presbia Margin History

Presbia Gross marginPresbia Profit marginPresbia EBIT marginPresbia Profit margin
2018-142.86 %-40,728.57 %-40,285.72 %
2017-592.86 %-119,392.86 %-121,414.28 %
2016-1,892.86 %-111,850 %-112,550 %
2015-6.54 %-11,849.67 %-11,869.93 %
201462.11 %-8,293.79 %-9,729.19 %
2013-13.27 %-7,425.51 %-9,655.1 %
201220 %-3,590 %-5,050 %
201180.95 %-961.9 %-1,376.19 %

Presbia Stock Sales Revenue, EBIT, Earnings per Share

The Presbia earnings per share therefore indicates how much revenue Presbia has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Presbia earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Presbia's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Presbia’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Presbia's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Presbia Revenue, EBIT and net profit per share

DatePresbia Sales per SharePresbia EBIT per sharePresbia Earnings per Share
20180 undefined-0.5 undefined-0.5 undefined
20170 undefined-1.03 undefined-1.04 undefined
20160 undefined-1.17 undefined-1.18 undefined
20150.01 undefined-1.4 undefined-1.4 undefined
20140.02 undefined-1.46 undefined-1.71 undefined
20130.01 undefined-0.55 undefined-0.71 undefined
20120.01 undefined-0.27 undefined-0.38 undefined
20110.02 undefined-0.15 undefined-0.22 undefined

Presbia business model

Presbia PLC is an iris-based microimplant company that was founded in 2006 under the name DermaLase Medical Corp. The company is headquartered in Dublin, Ireland, and also operates offices in the United States, Germany, South Korea, and Australia. Presbia's business model is to offer innovative solutions for the correction of presbyopia. The company has developed a technology based on a small-sized implant that is implanted in the eye to correct presbyopia. The implant is about the size of a pin and can be inserted in one or both eyes. The system uses a precise procedure based on sectoral focusing of infrared laser light and the light-reflective effect of iris tissue. Presbia specializes in the development and marketing of implants for the correction of presbyopia. Their flagship product is called Presbia Flexivue Microlens, which is approved in Europe and already being distributed in nine countries. The Microlens is a small, transparent sound implant that is inserted into the eye and allows for multifocal correction of presbyopia. It is reversible and can be easily removed if the patient wants to improve their vision or choose alternative correction options. The company is divided into two segments - the implant sales segment and the research and development segment. In 2019, Presbia achieved annual revenue of $2.4 million. The company also has a strong patent portfolio, giving them a competitive advantage in the industry. Presbia has formed partnerships with leading eyewear companies worldwide, allowing them to offer their products in a variety of markets. Their business growth is driven by increasing patient demand for presbyopia correction and the aging global population. The combination of innovation, technology, and patient care is crucial for Presbia in providing a better vision experience for patients worldwide. Their products are constantly being developed and improved to offer patients an optimal vision experience. Overall, Presbia is an exciting company for those seeking groundbreaking solutions for presbyopia correction. With their innovative product range, patented technologies, and strong focus on research and development, Presbia is an excellent choice for many patients looking to restore their vision. Presbia is one of the most popular companies on Eulerpool.com.

Presbia SWOT Analysis

Strengths

Presbia PLC has several key strengths that contribute to its success in the market. One of its main strengths is its innovative technology which offers a unique solution for the treatment of presbyopia. This technology has the potential to revolutionize the vision correction industry and provide significant benefits to patients.

Another strength of Presbia PLC is its strong intellectual property portfolio. The company holds a number of patents and trademarks that provide it with a competitive advantage and protect its innovative technology from potential imitators.

Weaknesses

Despite its strengths, Presbia PLC also faces certain weaknesses that could hinder its growth and market penetration. One of the main weaknesses is the limited geographic presence of the company. Presbia PLC currently operates in a few select markets, which limits its ability to reach a larger customer base and fully capitalize on its technology.

Additionally, as a relatively small company, Presbia PLC may face challenges in terms of resources and funding. Expanding its operations and marketing efforts require significant investments, which may strain the company's financial position.

Opportunities

Presbia PLC has several opportunities that it can leverage to expand its market share and increase its revenue. The growing global aging population presents a significant opportunity for the company, as presbyopia is a vision condition that affects a large portion of this demographic. By targeting this untapped market, Presbia PLC can significantly increase its customer base and generate additional sales.

Furthermore, strategic partnerships with established eyecare providers and distributors can also provide Presbia PLC with the opportunity to enhance its market presence and improve its distribution channels. Collaborations with industry leaders can facilitate the adoption of its technology and further strengthen its position in the market.

Threats

Presbia PLC faces several threats that could impact its business operations and market position. One of the key threats is the presence of well-established competitors in the vision correction industry. Large companies with extensive resources and established customer bases can pose a challenge to Presbia PLC's market share.

Moreover, regulatory hurdles and compliance requirements in different markets can also hinder the company's ability to expand globally. Adhering to varying regulations and obtaining necessary approvals can be time-consuming and costly for Presbia PLC, potentially delaying its market entry into new regions.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Presbia Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Presbia historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Presbia shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Presbia earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Presbia's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Presbia’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Presbia's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Presbia.

Presbia shareholders

%
Name
Stocks
Change
Date
9.58364 % Fidelity Management & Research Company LLC1,651,26107/31/2022
1

Presbia Executives and Management Board

Ms. Casey Lind

(58)
Presbia Chief Operating Officer
Compensation 507,119

Mr. Zohar Loshitzer

(60)
Presbia Chairman of the Board (since 2014)
Compensation 300,000

Mr. Mark Yung

(47)
Presbia Director (since 2017)
Compensation 250,000

Dr. Gerd Auffarth

(55)
Presbia Director
Compensation 135,000

Dr. Gerald Farrell

(60)
Presbia Director
Compensation 117,500
1
2

Most common questions regarding Presbia

What values and corporate philosophy does Presbia represent?

Presbia PLC is a company that represents values of innovation, commitment to excellence, and patient-focused approach. With a corporate philosophy rooted in the development of advanced ophthalmic solutions, Presbia aims to provide effective treatments to enhance vision and improve the quality of life for individuals suffering from presbyopia. By delivering cutting-edge technology and investing in research and development, Presbia is dedicated to revolutionizing the field of vision correction. Through its unwavering dedication to serving patients and utilizing breakthrough advancements, Presbia PLC continues to establish itself as a leader in the ophthalmic industry.

In which countries and regions is Presbia primarily present?

Presbia PLC is primarily present in Europe, including countries like Germany, France, Spain, Italy, and the United Kingdom. They also have a significant presence in Middle Eastern countries such as Saudi Arabia, United Arab Emirates, and Kuwait. Additionally, Presbia PLC operates in the Asia Pacific region, specifically in countries like Japan, South Korea, Australia, and Singapore. With their global reach, Presbia PLC aims to provide their innovative solutions for presbyopia treatment to a vast customer base in various countries and regions.

What significant milestones has the company Presbia achieved?

Presbia PLC has achieved several significant milestones over the years. In 2016, the company received approval from the U.S. Food and Drug Administration (FDA) for its Flexivue Microlens™, making it the first and only microlens approved for the treatment of presbyopia. This approval opened up new opportunities for Presbia in the global refractive vision correction market. In 2018, the company reached a major milestone by treating its 3,000th patient with the Flexivue Microlens™. This achievement highlights Presbia's dedication to providing a safe and effective solution for age-related vision loss. With its innovative product, Presbia PLC continues to make strides in the field of presbyopia correction.

What is the history and background of the company Presbia?

Presbia PLC is a renowned medical device company specializing in the treatment of presbyopia. Established in 2008, Presbia PLC has been at the forefront of developing innovative solutions for this common vision condition. The company's main product is the Presbia Flexivue Microlens™, a tiny lens insert that improves near vision and reduces the need for reading glasses. Presbia PLC boasts a team of experienced professionals dedicated to improving quality of life for presbyopia sufferers around the globe. With a strong emphasis on research and development, Presbia PLC continues to lead the market with safe and effective vision correction solutions.

Who are the main competitors of Presbia in the market?

Presbia PLC faces competition in the market from companies such as AcuFocus Inc., ReVision Optics Inc., and Kamra Vision.

In which industries is Presbia primarily active?

Presbia PLC is primarily active in the medical devices industry, specifically focusing on the development and commercialization of optical lens implants for the treatment of presbyopia, a common condition affecting near vision as people age. With its innovative Flexivue Microlens™ technology, Presbia aims to provide a convenient and long-term solution for individuals seeking to reduce dependence on reading glasses. Presbia's expertise lies in ophthalmology and ocular procedures, making it a key player in the medical devices sector, revolutionizing the way presbyopia is treated and improving the quality of life for patients worldwide.

What is the business model of Presbia?

The business model of Presbia PLC revolves around presbyopia-correcting optical lens technology. Presbia specializes in the development and commercialization of micro-optical lenses that are implanted into the cornea to treat presbyopia, a common age-related condition that affects near vision. By offering a minimally invasive alternative to traditional methods, Presbia aims to provide patients with improved vision and reduced dependence on reading glasses or contact lenses. Through its innovative lens technology and strategic partnerships, Presbia strives to meet the growing demand for effective solutions in presbyopia treatment, benefiting individuals worldwide.

What is the P/E ratio of Presbia 2025?

The P/E ratio cannot be calculated for Presbia at the moment.

What is the P/S ratio of Presbia 2025?

The P/S cannot be calculated for Presbia currently.

What is the Quality Investing of Presbia?

The Quality Investing for Presbia is 2/10.

What is the revenue of Presbia 2025?

The revenue cannot currently be calculated for Presbia.

How high is the profit of Presbia 2025?

The profit cannot currently be calculated for Presbia.

What is the business model of Presbia

Presbia PLC is an Irish multi-product company specializing in the development of innovative medical solutions. The company focuses on developing and selling products for the correction of age-related farsightedness, known as presbyopia, as well as drug development in the field of ophthalmology. The company's patented micro-lens implant called "Flexivue Microlens" is at the center of its focus. This implant is a tiny and foldable lens that is inserted into the eye to improve vision. The micro-lens implant was developed to ensure a safe and minimally invasive eye surgery and has already received CE marking (European approval process). Presbia PLC has already successfully implanted over 5,000 implants worldwide. The implant has a high customer satisfaction rate and improves vision for age-related farsightedness in a wide range of patients with different dioptic values. In addition to the micro-lens implant, Presbia PLC is also working on the development of drugs for the treatment of eye diseases. The company has already successfully conducted phase I and II clinical trials for the development of drugs for the treatment of eye diseases such as dry eye and optic neuritis. Presbia PLC distributes its products and solutions worldwide and has offices in Europe, Asia, and the US. The company uses a model based on strategic partnerships with ophthalmologists, clinics, and hospitals. The goal of Presbia PLC is to become the number one in the field of age-related vision correction and eye diseases while ensuring the highest quality and safety of its products. Overall, Presbia PLC is an extremely successful company that focuses on the development and marketing of highly innovative medical solutions. Through the use of strategic partnerships and a focus on the highest quality and safety of its products, the company has a strong position in the market and a great potential for future growth.

What is the Presbia dividend?

Presbia pays a dividend of 0 USD distributed over payouts per year.

How often does Presbia pay dividends?

The dividend cannot currently be calculated for Presbia or the company does not pay out a dividend.

What is the Presbia ISIN?

The ISIN of Presbia is IE00BJ0X7W22.

What is the Presbia ticker?

The ticker of Presbia is LENSF.

How much dividend does Presbia pay?

Over the past 12 months, Presbia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Presbia is expected to pay a dividend of 0 USD.

What is the dividend yield of Presbia?

The current dividend yield of Presbia is .

When does Presbia pay dividends?

Presbia pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Presbia?

Presbia paid dividends every year for the past 0 years.

What is the dividend of Presbia?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Presbia located?

Presbia is assigned to the 'Health' sector.

Wann musste ich die Aktien von Presbia kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Presbia from 2/17/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/17/2025.

When did Presbia pay the last dividend?

The last dividend was paid out on 2/17/2025.

What was the dividend of Presbia in the year 2024?

In the year 2024, Presbia distributed 0 USD as dividends.

In which currency does Presbia pay out the dividend?

The dividends of Presbia are distributed in USD.

All fundamentals about Presbia

Our stock analysis for Presbia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Presbia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.